Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Original Research

Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data

       
Total article views   HTML views PDF downloads Totals
13,543 Dovepress* 10,812+ 1,589 12,401
PubMed Central* 2,731 396 3,127
Totals 13,543 1,985 15,528
*Since 20 June 2012
+Since July 2016

View citations on PubMed and Google Scholar